| Year |
Citation |
Score |
| 2020 |
Erendor F, Sahin EO, Sanlioglu AD, Balci MK, Griffith TS, Sanlioglu S. Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation. Gene Therapy. PMID 32733091 DOI: 10.1038/S41434-020-0183-3 |
0.363 |
|
| 2018 |
Olgun HB, Tasyurek HM, Sanlioglu AD, Sanlioglu S. High-Grade Purification of Third-Generation HIV-Based Lentiviral Vectors by Anion Exchange Chromatography for Experimental Gene and Stem Cell Therapy Applications. Methods in Molecular Biology (Clifton, N.J.). PMID 30006865 DOI: 10.1007/7651_2018_154 |
0.341 |
|
| 2018 |
Tasyurek HM, Eksi YE, Sanlioglu AD, Altunbas HA, Balci MK, Griffith TS, Sanlioglu S. HIV-based lentivirus-mediated vasoactive intestinal peptide gene delivery protects against DIO animal model of Type 2 diabetes. Gene Therapy. PMID 29523882 DOI: 10.1038/S41434-018-0011-1 |
0.301 |
|
| 2018 |
Tasyurek HM, Altunbas HA, Balci MK, Griffith TS, Sanlioglu S. Therapeutic potential of lentivirus-mediated glucagon-like peptide-1 (GLP-1) gene therapy for diabetes. Human Gene Therapy. PMID 29409356 DOI: 10.1089/Hum.2017.180 |
0.307 |
|
| 2018 |
SAHIN EO, ERENDOR F, BALCI MK, SANLIOGLU S. Generation of a Novel Gene Therapy Vector Encoding Beta-Cell–Specific Insulin for Diabetes Treatment Diabetes. 67: 1780-P. DOI: 10.2337/Db18-1780-P |
0.341 |
|
| 2014 |
Timur M, Cort A, Ozdemir E, Sarikcioglu SB, Sanlioglu S, Sanlioglu AD, Ozben T. Bleomycin induced sensitivity to TRAIL/Apo-2L-mediated apoptosis in human seminomatous testicular cancer cells is correlated with upregulation of death receptors. Anti-Cancer Agents in Medicinal Chemistry. 15: 99-106. PMID 25173558 DOI: 10.2174/1871520614666140829130047 |
0.392 |
|
| 2014 |
Tasyurek MH, Altunbas HA, Canatan H, Griffith TS, Sanlioglu S. GLP-1-mediated gene therapy approaches for diabetes treatment. Expert Reviews in Molecular Medicine. 16: e7. PMID 24666581 DOI: 10.1017/Erm.2014.7 |
0.313 |
|
| 2012 |
Sanlioglu AD, Altunbas HA, Balci MK, Griffith TS, Sanlioglu S. Insulin gene therapy from design to beta cell generation. Expert Reviews in Molecular Medicine. 14: e18. PMID 23062285 DOI: 10.1017/Erm.2012.12 |
0.313 |
|
| 2012 |
Sanlioglu AD, Karacay B, Balci MK, Griffith TS, Sanlioglu S. Therapeutic potential of VIP vs PACAP in diabetes. Journal of Molecular Endocrinology. 49: R157-67. PMID 22991228 DOI: 10.1530/Jme-12-0156 |
0.337 |
|
| 2011 |
Dirice E, Kahraman S, Elpek GO, Aydin C, Balci MK, Omer A, Sanlioglu S, Sanlioglu AD. TRAIL and DcR1 expressions are differentially regulated in the pancreatic islets of STZ- versus CY-applied NOD mice. Experimental Diabetes Research. 2011: 625813. PMID 22144989 DOI: 10.1155/2011/625813 |
0.326 |
|
| 2011 |
Yoldas B, Ozer C, Ozen O, Canpolat T, Dogan I, Griffith TS, Sanlioglu S, Ozluoglu LN. Clinical significance of TRAIL and TRAIL receptors in patients with head and neck cancer. Head & Neck. 33: 1278-84. PMID 21837697 DOI: 10.1002/Hed.21598 |
0.326 |
|
| 2010 |
Aydin C, Sanlioglu AD, Bisgin A, Yoldas B, Dertsiz L, Karacay B, Griffith TS, Sanlioglu S. NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL. Bmc Cancer. 10: 584. PMID 20977779 DOI: 10.1186/1471-2407-10-584 |
0.385 |
|
| 2010 |
Bisgin A, Terzioglu E, Aydin C, Yoldas B, Yazisiz V, Balci N, Bagci H, Gorczynski RM, Akdis CA, Sanlioglu S. TRAIL death receptor-4, decoy receptor-1 and decoy receptor-2 expression on CD8+ T cells correlate with the disease severity in patients with rheumatoid arthritis. Bmc Musculoskeletal Disorders. 11: 192. PMID 20799941 DOI: 10.1186/1471-2474-11-192 |
0.324 |
|
| 2010 |
Koksal IT, Sanlioglu AD, Kutlu O, Sanlioglu S. Effects of androgen ablation therapy in TRAIL death ligand and its receptors expression in advanced prostate cancer. Urologia Internationalis. 84: 445-51. PMID 20339295 DOI: 10.1159/000304510 |
0.308 |
|
| 2009 |
Korcum AF, Sanlioglu S, Aksu G, Tuncel N, Erin N. Radiotherapy-induced decreases in substance P levels may potentiate melanoma growth. Molecular Medicine Reports. 2: 319-26. PMID 21475832 DOI: 10.3892/Mmr_00000103 |
0.3 |
|
| 2009 |
Sanlioglu AD, Dirice E, Elpek O, Korcum AF, Ozdogan M, Suleymanlar I, Balci MK, Griffith TS, Sanlioglu S. High TRAIL death receptor 4 and decoy receptor 2 expression correlates with significant cell death in pancreatic ductal adenocarcinoma patients. Pancreas. 38: 154-60. PMID 18981952 DOI: 10.1097/Mpa.0B013E31818Db9E3 |
0.349 |
|
| 2008 |
Sanlioglu AD, Dirice E, Elpek O, Korcum AF, Balci MK, Omer A, Griffith TS, Sanlioglu S. High levels of endogenous tumor necrosis factor-related apoptosis-inducing ligand expression correlate with increased cell death in human pancreas. Pancreas. 36: 385-93. PMID 18437085 DOI: 10.1097/Mpa.0B013E318158A4E5 |
0.395 |
|
| 2008 |
Koksal IT, Sanlioglu AD, Karacay B, Griffith TS, Sanlioglu S. Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in patients with prostate carcinoma. Urologic Oncology. 26: 158-65. PMID 18312935 DOI: 10.1016/J.Urolonc.2007.01.022 |
0.335 |
|
| 2008 |
Sanlioglu AD, Griffith TS, Omer A, Dirice E, Sari R, Altunbas HA, Balci MK, Sanlioglu S. Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetes. Journal of Cellular Biochemistry. 104: 710-20. PMID 18247339 DOI: 10.1002/Jcb.21677 |
0.329 |
|
| 2008 |
Sanlioglu AD, Dirice E, Elpek O, Korcum AF, Balci MK, Omer A, Griffith TS, Sanlioglu S. Differential alteration of TRAIL and its receptor expression profiles in patients with pancreatic ductal adenocarcinoma Journal of Clinical Oncology. 26: 15607-15607. DOI: 10.1200/Jco.2008.26.15_Suppl.15607 |
0.307 |
|
| 2007 |
Aslan M, Yucel I, Ciftcioglu A, SavaÅŸ B, Akar Y, Yucel G, Sanlioglu S. Corneal protein nitration in experimental uveitis. Experimental Biology and Medicine (Maywood, N.J.). 232: 1308-13. PMID 17959843 DOI: 10.3181/0702-Rm-34 |
0.316 |
|
| 2007 |
Sanlioglu AD, Karacay B, Koksal IT, Griffith TS, Sanlioglu S. DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells. Cancer Gene Therapy. 14: 976-84. PMID 17853923 DOI: 10.1038/Sj.Cgt.7701087 |
0.367 |
|
| 2007 |
Sanlioglu AD, Korcum AF, Pestereli E, Erdogan G, Karaveli S, Savas B, Griffith TS, Sanlioglu S. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma. International Journal of Radiation Oncology, Biology, Physics. 69: 716-23. PMID 17512128 DOI: 10.1016/J.Ijrobp.2007.03.057 |
0.332 |
|
| 2007 |
Terzioglu E, Bisgin A, Sanlioglu AD, Ulker M, Yazisiz V, Tuzuner S, Sanlioglu S. Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis. Rheumatology (Oxford, England). 46: 783-9. PMID 17309888 DOI: 10.1093/Rheumatology/Kel448 |
0.337 |
|
| 2007 |
Aydin C, Sanlioglu AD, Karacay B, Ozbilim G, Dertsiz L, Ozbudak O, Akdis CA, Sanlioglu S. Decoy receptor-2 small interfering RNA (siRNA) strategy employing three different siRNA constructs in combination defeats adenovirus-transferred tumor necrosis factor-related apoptosis-inducing ligand resistance in lung cancer cells. Human Gene Therapy. 18: 39-50. PMID 17187448 DOI: 10.1089/Hum.2006.111 |
0.37 |
|
| 2007 |
Sanlioglu AD, Koksal IT, Ciftcioglu A, Baykara M, Luleci G, Sanlioglu S. Differential expression of TRAIL and its receptors in benign and malignant prostate tissues. The Journal of Urology. 177: 359-64. PMID 17162091 DOI: 10.1016/J.Juro.2006.08.087 |
0.303 |
|
| 2006 |
Sanlioglu AD, Koksal IT, Karacay B, Baykara M, Luleci G, Sanlioglu S. Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis. Cancer Gene Therapy. 13: 21-31. PMID 16052230 DOI: 10.1038/Sj.Cgt.7700877 |
0.408 |
|
| 2006 |
Smeyne RJ, Chu T, Lewin A, Bian F, Sanlioglu S, Kunsch C, Lira SA, Oberdick J. Corrigendum to "Local control of granule cell generation by cerebellar purkinje cells" [Mol. Cell. Neurosci. 6 (1995) 230-251] (DOI:10.1006/j.mcn.1995.10.019) Molecular and Cellular Neuroscience. 32: 215. DOI: 10.1016/J.Mcn.2006.04.001 |
0.692 |
|
| 2005 |
Koksal IT, Yasar D, Dirice E, Usta MF, Karauzum S, Luleci G, Baykara M, Sanlioglu S. Differential PTEN protein expression profiles in superficial versus invasive bladder cancers. Urologia Internationalis. 75: 102-6. PMID 16123561 DOI: 10.1159/000085933 |
0.321 |
|
| 2005 |
Sanlioglu AD, Dirice E, Aydin C, Erin N, Koksoy S, Sanlioglu S. Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells. Bmc Cancer. 5: 54. PMID 15916713 DOI: 10.1186/1471-2407-5-54 |
0.406 |
|
| 2004 |
Karacay B, Sanlioglu S, Griffith TS, Sandler A, Bonthius DJ. Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells. Cancer Gene Therapy. 11: 681-90. PMID 15332116 DOI: 10.1038/Sj.Cgt.7700749 |
0.364 |
|
| 2004 |
Sanlioglu AD, Karacay B, Benson PK, Engelhardt JF, Sanlioglu S. Novel approaches to augment adeno-associated virus type-2 endocytosis and transduction. Virus Research. 104: 51-9. PMID 15177892 DOI: 10.1016/J.Virusres.2004.03.002 |
0.392 |
|
| 2004 |
Sanlioglu AD, Aydin C, Bozcuk H, Terzioglu E, Sanlioglu S. Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma. Lung Cancer (Amsterdam, Netherlands). 44: 199-211. PMID 15084385 DOI: 10.1016/J.Lungcan.2003.11.017 |
0.326 |
|
| 2002 |
Doerschug K, Sanlioglu S, Flaherty DM, Wilson RL, Yarovinsky T, Monick MM, Engelhardt JF, Hunninghake GW. First-generation adenovirus vectors shorten survival time in a murine model of sepsis. Journal of Immunology (Baltimore, Md. : 1950). 169: 6539-45. PMID 12444165 DOI: 10.4049/Jimmunol.169.11.6539 |
0.316 |
|
| 2001 |
Sanlioglu S, Luleci G, Thomas KW. Simultaneous inhibition of Rac1 and IKK pathways sensitizes lung cancer cells to TNFalpha-mediated apoptosis. Cancer Gene Therapy. 8: 897-905. PMID 11773980 DOI: 10.1038/Sj.Cgt.7700394 |
0.369 |
|
| 2001 |
Li Q, Sanlioglu S, Li S, Ritchie T, Oberley L, Engelhardt JF. GPx-1 gene delivery modulates NFkappaB activation following diverse environmental injuries through a specific subunit of the IKK complex. Antioxidants & Redox Signaling. 3: 415-32. PMID 11491654 DOI: 10.1089/15230860152409068 |
0.349 |
|
| 2000 |
Sanlioglu S, Benson P, Engelhardt JF. Loss of ATM function enhances recombinant adeno-associated virus transduction and integration through pathways similar to UV irradiation. Virology. 268: 68-78. PMID 10683328 DOI: 10.1006/Viro.1999.0137 |
0.356 |
|
| 1999 |
Baader SL, Vogel MW, Sanlioglu S, Zhang X, Oberdick J. Selective disruption of "late onset" sagittal banding patterns by ectopic expression of engrailed-2 in cerebellar Purkinje cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 5370-9. PMID 10377347 DOI: 10.1523/Jneurosci.19-13-05370.1999 |
0.705 |
|
| 1999 |
Duan D, Sharma P, Dudus L, Zhang Y, Sanlioglu S, Yan Z, Yue Y, Ye Y, Lester R, Yang J, Fisher KJ, Engelhardt JF. Formation of adeno-associated virus circular genomes is differentially regulated by adenovirus E4 ORF6 and E2a gene expression. Journal of Virology. 73: 161-9. PMID 9847318 DOI: 10.1128/Jvi.73.1.161-169.1999 |
0.318 |
|
| 1998 |
Sanlioglu S, Zhang X, Baader SL, Oberdick J. Regulation of a Purkinje cell-specific promoter by homeodomain proteins: repression by engrailed-2 vs. synergistic activation by Hoxa5 and Hoxb7. Journal of Neurobiology. 36: 559-71. PMID 9740027 DOI: 10.1002/(Sici)1097-4695(19980915)36:4<559::Aid-Neu9>3.0.Co;2-V |
0.704 |
|
| 1998 |
Baader SL, Sanlioglu S, Berrebi AS, Parker-Thornburg J, Oberdick J. Ectopic overexpression of engrailed-2 in cerebellar Purkinje cells causes restricted cell loss and retarded external germinal layer development at lobule junctions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 1763-73. PMID 9465001 DOI: 10.1523/Jneurosci.18-05-01763.1998 |
0.761 |
|
| 1998 |
Baader SL, Sanlioglu S, Berrebi AS, Parker-Thornburg J, Oberdick J. Ectopic Overexpression of Engrailed-2 in Cerebellar Purkinje Cells Causes Restricted Cell Loss and Retarded External Germinal Layer Development at Lobule Junctions The Journal of Neuroscience. 18: 1763-1773. DOI: 10.1523/JNEUROSCI.18-05-01763.1998 |
0.737 |
|
| 1995 |
Smeyne RJ, Chu T, Lewin A, Bian F, Sanlioglu S, S-Crisman S, Kunsch C, Lira SA, Oberdick J. Local control of granule cell generation by cerebellar Purkinje cells. Molecular and Cellular Neurosciences. 6: 230-51. PMID 7496629 DOI: 10.1006/Mcne.1995.1019 |
0.747 |
|
| Show low-probability matches. |